Kurzfassung:
New molecular M2L4 cages for the targeted drug delivery of cisplatin in tumor cells are presented. These complexes are capable of encapsulating cisplatin and hereby enhance its effectiveness against cancer cells. Furthermore, a new ambidentate N-heterocyclic silane ligand is reported, which forms novel complexes with iridium and rhodium salts. For rhodium, this leads to a yet unprecedented, electronically induced coordination change.